Page 8 - Drug Makers In India

Govt moves to check over-the-counter selling of coronavirus drugs

Sensing serious health risks, the government has swung into action. Dispensing of these medicines would get stricter and states have started collecting information on available stock in the market

Ample drug ingredients for next 3 months; monitoring situation, says Govt

All initiatives are being taken to ensure there is no impact of the disease in India, Minister of Chemicals and Fertilizers D V Sadananda Gowda said

Govt sanctions Rs 1,850 cr to ensure better drug monitoring systems

A significant share of this money will go into upgrading the Sugam portal - the e-governance solution for CDSCO.

Coronavirus impact: Icra downgrades domestic pharma outlook to negative

According to Icra research, domestic API manufacturers have an inventory of one-two months

In a booster dose, pharma industry gets 'green' signal in New Year

Drug makers allowed to tweak product mix or quantity without fresh environment clearance until effluent load is same

Drug controller cracks whip on e-pharmacies selling drugs without licences

Last December the Delhi High Court had said online sale of medicines without a licence was injuncted, and had instructed the government to ensure that the same was prohibited forthwith

Indian pharmaceutical companies spread business to avoid regulatory ire

Increased USFDA import alerts could be reason for finding alternative sites

The antibiotics challenge

Don't extend price caps on drugs

Domestic drug portfolio a key driver of Ajanta Pharma's growth prospects

Industry beating growth along with high US sales are keeping analysts positive on the company's earnings prospects

Drug marketers to be held liable for quality churned out by third parties

Onus of quality and labelling is currently with drug maker, marketers just need licence to sell. Rule change will make marketers more accountable, greater scrutiny may boost quality, say experts